CD34 and acute myeloid leukemia: These agents induced almost complete glutathione depletion and severe cell death in CD34+ AML cells and proposed that these possible novel agents could overcome chemotherapy resistance in comparison to standard chemotherapy agents (Pei et al., 2013).